---
figid: PMC6727394__13045_2019_776_Fig1_HTML
figlink: /pmc/articles/PMC6727394/figure/Fig1/
number: F1
caption: Schematic representation of altered metabolic pathways and associated circRNAs
  in cancer. The characteristic features include two aspects. First, it illustrates
  deregulated uptake of glucose and amino acids, overactive fatty acid synthesis and
  oxidation, and NADPH overproduction. Second, it shows how circRNAs interact with
  these metabolic pathways by enzymes and TFs. HIF1-α and c-myc can adjust the Warburg
  effect-relevant enzymes and transporters. The majority of circRNAs can antagonize
  miRNAs to indirectly produce effects. In addition, circ-Amotl1 and circ_FBXW7 can
  directly affect TFs. The circRNAs in the dark blue rounded rectangle are considered
  to function in cancer cells, while the circRNAs in the light blue rounded rectangle
  are just proved to function in normal cells. miRNAs are in the green rectangle;
  the components affecting metabolism are in faint yellow rectangle. The positive
  relationships are shown by arrows, and the negative relationships are shown by short
  dashes. ACC, acetyl-COA carboxylase; ACSL, acyl-CoA synthetases; ASCT2, neutral
  amino acid transporter2; BC, breast cancer; CPT1, carnitine palmitoyltransferase
  1; CRC, colorectal cancer; FAO, fatty acids β-oxidation; FASN, fatty acid synthase;
  FAT, fatty acid translocase; GLS, glutaminase; GLUD1, glutamate dehydrogenase; GLUT,
  glutamate dehydrogenase; HCC, hepatocellular carcinoma; HK, hexokinase; LDHA, lactate
  dehydrogenase A; LUAD, lung adenocarcinoma; MCT. monocarboxylate transporter; PCa,
  prostate cancer; PDH, pyruvate dehydrogenase; PDK, pyruvate dehydrogenase kinase;
  PFK, 6-phosphfructa-1-kinase; PKM2, Pyruvate kinase isozymes M2; PPP, pentose phosphate
  pathway; α-KG, α-ketoglutarate. (Red lines, catabolic pathways; orange lines, glutamine
  pathways; green lines, lipid pathways)
pmcid: PMC6727394
papertitle: 'CircRNAs in cancer metabolism: a review.'
reftext: Tao Yu, et al. J Hematol Oncol. 2019;12:90.
pmc_ranked_result_index: '33267'
pathway_score: 0.9666889
filename: 13045_2019_776_Fig1_HTML.jpg
figtitle: Altered metabolic pathways and associated circRNAs in cancer
year: '2019'
organisms:
- Mus musculus
- Homo sapiens
ndex: 3a1df64f-decf-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6727394__13045_2019_776_Fig1_HTML.html
  '@type': Dataset
  description: Schematic representation of altered metabolic pathways and associated
    circRNAs in cancer. The characteristic features include two aspects. First, it
    illustrates deregulated uptake of glucose and amino acids, overactive fatty acid
    synthesis and oxidation, and NADPH overproduction. Second, it shows how circRNAs
    interact with these metabolic pathways by enzymes and TFs. HIF1-α and c-myc can
    adjust the Warburg effect-relevant enzymes and transporters. The majority of circRNAs
    can antagonize miRNAs to indirectly produce effects. In addition, circ-Amotl1
    and circ_FBXW7 can directly affect TFs. The circRNAs in the dark blue rounded
    rectangle are considered to function in cancer cells, while the circRNAs in the
    light blue rounded rectangle are just proved to function in normal cells. miRNAs
    are in the green rectangle; the components affecting metabolism are in faint yellow
    rectangle. The positive relationships are shown by arrows, and the negative relationships
    are shown by short dashes. ACC, acetyl-COA carboxylase; ACSL, acyl-CoA synthetases;
    ASCT2, neutral amino acid transporter2; BC, breast cancer; CPT1, carnitine palmitoyltransferase
    1; CRC, colorectal cancer; FAO, fatty acids β-oxidation; FASN, fatty acid synthase;
    FAT, fatty acid translocase; GLS, glutaminase; GLUD1, glutamate dehydrogenase;
    GLUT, glutamate dehydrogenase; HCC, hepatocellular carcinoma; HK, hexokinase;
    LDHA, lactate dehydrogenase A; LUAD, lung adenocarcinoma; MCT. monocarboxylate
    transporter; PCa, prostate cancer; PDH, pyruvate dehydrogenase; PDK, pyruvate
    dehydrogenase kinase; PFK, 6-phosphfructa-1-kinase; PKM2, Pyruvate kinase isozymes
    M2; PPP, pentose phosphate pathway; α-KG, α-ketoglutarate. (Red lines, catabolic
    pathways; orange lines, glutamine pathways; green lines, lipid pathways)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HIF1A
  - CHPT1
  - ACSL6
  - ACSL1
  - ACSL3
  - ACSL4
  - FASN
  - CD36
  - ACSL5
  - SLC1A5
  - SLC2A1
  - FAM126A
  - ACACA
  - LIN9
  - LDHA
  - FLVCR1
  - DLAT
  - DLD
  - PDHA1
  - MYC
  - PDHB
  - GLS
  - GLUD1
  - PDK1
  - PDK2
  - PDK3
  - ACACB
  - PKM
  - PDHA2
  - PDHX
  - PDK4
  - glucose
  - PUFA
  - Glucose-6-P
  - NADPH
  - Palmitate
  - Fructose-6-P
  - Fructose-1,6-BP
  - Malonyl-CoA
  - glutamine
  - Glyceraldehyde-3-P
  - Citrate
  - Phosphoenolpyruvate
  - TCA
  - Glutamate
  - Pyruvate
  - Acetyl COA
  - Acyl
  - lactate
  - Glioma
genes:
- word: HIF1-a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: CPT1
  symbol: CPT1
  source: hgnc_alias_symbol
  hgnc_symbol: CHPT1
  entrez: '56994'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL6
  entrez: '23305'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL1
  entrez: '2180'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL3
  entrez: '2181'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL4
  entrez: '2182'
- word: FASN
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: FAT
  symbol: FAT
  source: hgnc_alias_symbol
  hgnc_symbol: CD36
  entrez: '948'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL5
  entrez: '51703'
- word: ASCT2
  symbol: ASCT2
  source: hgnc_alias_symbol
  hgnc_symbol: SLC1A5
  entrez: '6510'
- word: GLUT
  symbol: GLUT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: 'HCC:'
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: Phospholipids/TGs
  symbol: TGS
  source: hgnc_alias_symbol
  hgnc_symbol: LIN9
  entrez: '286826'
- word: LDHA
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
- word: 'PCa:'
  symbol: PCA
  source: hgnc_alias_symbol
  hgnc_symbol: FLVCR1
  entrez: '28982'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: C-myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: GLS
  symbol: GLS
  source: hgnc_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: GLUD1
  symbol: GLUD1
  source: hgnc_symbol
  hgnc_symbol: GLUD1
  entrez: '2746'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
chemicals:
- word: glucose
  source: MESH
  identifier: D005947
- word: PUFA
  source: MESH
  identifier: D015525
- word: Glucose-6-P
  source: MESH
  identifier: D005947
- word: NADPH
  source: MESH
  identifier: D009249
- word: Palmitate
  source: MESH
  identifier: D010168
- word: Fructose-6-P
  source: MESH
  identifier: D005632
- word: Fructose-1,6-BP
  source: MESH
  identifier: D005632
- word: Malonyl-CoA
  source: MESH
  identifier: D008316
- word: glutamine
  source: MESH
  identifier: C578860
- word: Glyceraldehyde-3-P
  source: MESH
  identifier: D005985
- word: Citrate
  source: MESH
  identifier: C102006
- word: Phosphoenolpyruvate
  source: MESH
  identifier: D010728
- word: TCA
  source: MESH
  identifier: C000589078
- word: Glutamate
  source: ''
  identifier: ''
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Acetyl COA
  source: MESH
  identifier: C479798
- word: Acyl
  source: MESH
  identifier: D000214
- word: lactate
  source: MESH
  identifier: D019344
diseases:
- word: Glioma
  source: MESH
  identifier: D005910
figid_alias: PMC6727394__F1
redirect_from: /figures/PMC6727394__F1
figtype: Figure
---
